Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.30.2 (
endonuclease
)
18,621
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Restriction
endonuclease
maps were constructed for the genome of a porcine adenovirus (PAV),
NADC-1
, which was isolated in 1972 from an adult swine. Genomic DNA libraries of
NADC-1
Bam HI, Eco RI/Bam HI, and Sph I fragments were cloned into pUC-18. Using the cloned
NADC-1
Bam HI and Eco RI/Bam HI fragments as probes, Southern blot hybridizations were performed to human adenovirus 2 (Ad-2) restriction fragments to determine the left-to-right orientation of the Bam HI and Eco RI/Bam HI fragments. Genomic
NADC-1
DNA was cleaved with ten restriction endonucleases (RE). Using cloned
NADC-1
genomic fragments as probes in Southern blot hybridizations, an RE site map was constructed. Nucleotide sequencing of four clones confirmed several RE sites. The size of the
NADC-1
genome was determined to be approximately 32 kbp. The size of Hind III, Xba I, Sma I, Eco RI, Bam HI, Bgl II, Pst I, and Sph I RE fragments from
NADC-1
was compared to those from the reference strain of PAV serotype 4 (F618), and to two recent isolates, NADC-2 and NADC-3. For all restriction enzymes examined, the sizes of the
NADC-1
fragments were identical to PAV-4, NADC-2, and NADC-3 fragments, indicating that the
NADC-1
isolate is very closely related, if not identical, to PAV-4 and two recent isolates. Southern blot hybridizations also indicated that
NADC-1
, NADC-2, NADC-3, and PAV-4 are very similar and revealed regions of sequence similarity between
NADC-1
and human Ad-2 and human Ad-5.
...
PMID:Genomic cloning and restriction site mapping of a porcine adenovirus isolate: demonstration of genomic stability in porcine adenovirus. 790 36